Text Size

Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood

This study is currently recruiting participants.
Verified July 2012 by Hospital Universitario Getafe
Sponsor:
Information provided by (Responsible Party):
Susana Arias Rivera, Hospital Universitario Getafe
ClinicalTrials.gov Identifier:
NCT01646008
First received: July 18, 2012
Last updated: July 19, 2012
Last verified: July 2012
History of Changes
  Purpose

The purpose of this study is to study the correlation between carbon dioxide measured by capnography at the enf of exhalation and arterial blood in COPD patients with nasal cannula in critical care unit.


Condition Intervention
Determine the Correlation Between Exhaled Carbon Dioxide and in Arterial Blood
 Other: To measure carbon dioxide by capnography and arterial blood
Other: to measure carbon dioxide by capnography and arterial blood

Study Type: Observational
Study Design: Time Perspective: Prospective
Official Title: Correlation Between Carbon Dioxide Measured in End of Exhalation and Arterial Blood in Chronic Obstructive Pulmonary Disease (COPD) in Intensive Care Unit With Nasal Cannula

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hospital Universitario Getafe:

Estimated Enrollment: 30
Study Start Date: July 2012
Groups/Cohorts Assigned Interventions
respiratory Other: To measure carbon dioxide by capnography and arterial blood
Three times per day will be measured exhaled carbon dioxide and obtained in arterial blood sample.
Other: to measure carbon dioxide by capnography and arterial blood
three times per day we will obtained arterial blood samples and measurements of carbon dioxide by capnography

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

All adult COPD patients admitted to the ICU who consent

Criteria

Inclusion Criteria:

  • Adults
  • COPD patients

Exclusion Criteria:

  • Under-aged
  • Pregnant
  • Major burns
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01646008

Contacts
Contact: Susana Arias-Rivera, Graduate 916839360 ext 2459 sarias.hugf@salud.madrid.org
Contact: Maria M Sanchez Sanchez, graduate 916839360 ext 2370 marwestpot@yahoo.es

Locations
Spain
Hospital Universitario de Getafe Recruiting
Getafe, Madrid, Spain, 28905
Contact: Susana Arias-Rivera, Graduate     916839360 ext 2459     sarias.hugf@salud.madrid.org    
Sponsors and Collaborators
Hospital Universitario Getafe
Investigators
Principal Investigator: Susana Arias-Rivera, Graduate Hospital Universitario de Getafe, Spain
  More Information

No publications provided

Responsible Party: Susana Arias Rivera, Registered Nurse, Hospital Universitario Getafe
ClinicalTrials.gov Identifier: NCT01646008     History of Changes
Other Study ID Numbers: Carbon dioxide Getafe
Study First Received: July 18, 2012
Last Updated: July 19, 2012
Health Authority: Spain: Comité Ético de Investigación Clínica

Additional relevant MeSH terms:
Pulmonary Disease, Chronic Obstructive
Lung Diseases, Obstructive
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on May 16, 2013